Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.

ABSTRACT: Aim: Despite evidence of racial/ethnicity health inequities in oral anticoagulant initiation and clinical outcomes for nonvalvular atrial fibrillation, little is known about disparities in treatment patterns, particularly discontinuation and switching. Materials & methods: This retrospective study utilized Komodo Healthcare Map data (1 July 2018 to 30 June 2023) to examine treatment patterns in patients with nonvalvular atrial fibrillation initiating direct oral anticoagulants (DOACs: apixaban, rivaroxaban, dabigatran) versus warfarin, stratified by self-reported race/ethnicity (White, Black and Hispanic) in the USA. Inverse probability of treatment weighting balanced baseline covariates and Cox model computed adjusted hazard ratio (aHR) and 95% confidence interval (CI) for a

SUBMITTER: Zhang M 

PROVIDER: S-EPMC12403335 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature